EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) 21. Září 2017, rubrika EUDA news
9. Červen 2026 New health risks for Europeans in a fast-moving drug market People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This...
